Ee Lyn Lim

1.5k total citations
9 papers, 1.0k citations indexed

About

Ee Lyn Lim is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ee Lyn Lim has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Ee Lyn Lim's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ee Lyn Lim is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ee Lyn Lim collaborates with scholars based in United Kingdom, Japan and United States. Ee Lyn Lim's co-authors include Klaus Okkenhaug, Dalya R. Soond, Khaled Ali, Bart Vanhaesebroeck, Hicham Bouabe, Roberto Piñeiro, Timothy C. Hancox, Wayne Pearce, Cheryl L. Scudamore and Lori S. Friedman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Ee Lyn Lim

9 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ee Lyn Lim United Kingdom 9 550 438 351 141 93 9 1.0k
José La Rose Canada 15 585 1.1× 526 1.2× 503 1.4× 77 0.5× 52 0.6× 22 1.2k
Evelina Martinenaite Denmark 17 450 0.8× 338 0.8× 176 0.5× 109 0.8× 32 0.3× 33 734
Yingzi Ge Germany 16 665 1.2× 600 1.4× 419 1.2× 150 1.1× 30 0.3× 22 1.2k
Hugues Duvillier Belgium 16 656 1.2× 631 1.4× 259 0.7× 32 0.2× 61 0.7× 33 1.1k
Ami Goradia United States 8 334 0.6× 543 1.2× 436 1.2× 52 0.4× 184 2.0× 10 1.1k
Huifeng Niu United States 13 251 0.5× 290 0.7× 362 1.0× 149 1.1× 267 2.9× 17 783
Ninib Baryawno Sweden 16 213 0.4× 292 0.7× 586 1.7× 122 0.9× 38 0.4× 35 1.1k
Nicole Boucheron Austria 17 1.0k 1.9× 291 0.7× 477 1.4× 53 0.4× 31 0.3× 29 1.4k
Torill Høiby Norway 6 269 0.5× 255 0.6× 318 0.9× 53 0.4× 45 0.5× 8 658

Countries citing papers authored by Ee Lyn Lim

Since Specialization
Citations

This map shows the geographic impact of Ee Lyn Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ee Lyn Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ee Lyn Lim more than expected).

Fields of papers citing papers by Ee Lyn Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ee Lyn Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ee Lyn Lim. The network helps show where Ee Lyn Lim may publish in the future.

Co-authorship network of co-authors of Ee Lyn Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Ee Lyn Lim. A scholar is included among the top collaborators of Ee Lyn Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ee Lyn Lim. Ee Lyn Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lim, Ee Lyn, Oliver Thieck, Thomas Magg, et al.. (2024). Disrupted degradative sorting of TLR7 is associated with human lupus. Science Immunology. 9(92). eadi9575–eadi9575. 38 indexed citations
2.
Wing, James B., Ee Lyn Lim, & Shimon Sakaguchi. (2020). Control of foreign Ag‐specific Ab responses by Treg and Tfr. Immunological Reviews. 296(1). 104–119. 46 indexed citations
3.
Lim, Ee Lyn & Klaus Okkenhaug. (2019). Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy. Immunology. 157(3). 210–218. 26 indexed citations
4.
Győri, Dávid, Ee Lyn Lim, Francis M. Grant, et al.. (2018). Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy. JCI Insight. 3(11). 104 indexed citations
5.
Ha, Danbee, Atsushi Tanaka, Tatsuya Kibayashi, et al.. (2018). Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody. Proceedings of the National Academy of Sciences. 116(2). 609–618. 153 indexed citations
6.
Lim, Ee Lyn, et al.. (2018). Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors. JCI Insight. 3(11). 40 indexed citations
7.
Ali, Khaled, Dalya R. Soond, Roberto Piñeiro, et al.. (2014). Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 510(7505). 407–411. 397 indexed citations
8.
So, Alex Yick‐Lun, Aadel A. Chaudhuri, David Cheng, et al.. (2014). Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. Blood. 124(9). 1502–1512. 49 indexed citations
9.
Li, Mulin Jun, Panwen Wang, Xiaorong Liu, et al.. (2011). GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Research. 40(D1). D1047–D1054. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026